None listed
Conditions
Interventions
Intervention1: Standard protein mix and Probiotic containing B. coagulans: 2 sachets to be taken orally with water twice daily, at approximately the same time each day, preferably morning and night fo
Sponsors
Abode Biotec India Private Limited
Eligibility
Inclusion criteria
Inclusion criteria: 1.Subject has provided written and dated informed consent to participate in the study. 2.Subject is willing and able to comply with the protocol. 3.Healthy male/female of age 18-60 years (both inclusive). 4.Subject is in good health as determined by Principal Investigator
Exclusion criteria
Exclusion criteria: 1.Subject on protein and/ or probiotic rich diet. 2.Subject is participating in another clinical trial or has received an investigational product within thirty days prior to enrolment. 3.Subject has a history of alcohol or other drug abuse in the past year 4.Subject has any medical condition or uses any medication, nutritional product, dietary supplement or program, which in the opinion of the investigator, might interfere with the conduct of the study or place the subject at risk.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Change in urine urea nitrogen for Bacillus coagulans-based product on protein absorption 2.Short Health Scale for GI symptoms (SHS-GI) for Bacillus coagulans-based product on protein absorption 3.Food frequency questionnaire (FFQs)Timepoint: 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety of Bacillus coagulans-based product on protein absorptionTimepoint: 8 Weeks | — |
Countries
India
Contacts
Public ContactDivya C
Bioagile Therapeutics Pvt. Ltd
Outcome results
None listed